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History and Epidemiology of Global 
Smallpox Eradication 
Smallpox 
 
 Three Egyptian 
Mummies  
1570-1085 BC 
 
Ramses the Vth 
Died 1157 BC 
Early Written Description of Smallpox 
India 400 AD 
“Severe pain is felt in the large and small joints, 
with cough, shaking, listlessness and langour; the 
palate, lips, and tongue are dry with thirst and no 
appetite. The pustules are red, yellow, and white 
and they are accompanied by burning pain. The 
form soon ripens …the body has a blue color and 
seems studded with rice. The pustules become 
black and flat, are depressed in the centre, with 
much pain.” 
Smallpox and History 
• In the Elephant war in Mecca 568 AD, 
smallpox  decimated the Ethiopian soldiers 
• Introduction of smallpox into the new world 
(Carribean 1507, Mexico 1520, Peru 1524, 
and Brazil 1555 ) facilitated Spanish conquest 
• Smallpox destroys Hottentots (1713) 
• In 1738, smallpox killed half the Cherokee 
Indian population 
• Smallpox disrupted colonial army in 1776 
Smallpox Control Strategies 
• Smallpox hospitals (Japan 982 AD). 
• Variolation 10th Century. 
• Quarantine 1650s. 
• Home isolation of smallpox in Virginia 1667. 
• Inoculation and isolation (Haygarth 1793). 
• Jenner and widespread practice of vaccination 
throughout Europe and rest of the world. 
• Mass vaccination. 
• Surveillance containment. 
Variolation Inoculation  
with Smallpox Pus 
• Observations: 
– Pocked marked persons never affected with 
smallpox 
– Persons inoculated with smallpox pustular 
fluid or dried scabs usually had milder disease 
• Not ideal control strategy  
– Case fatality rate still 2% 
– Can transmit disease to others during illness 
 
 
The 1st   Smallpox Vaccination 
Jenner 1796  
Cowpox lesions on the hand of Sarah Nelmes  
(case XVI in Jenner’s Inquiry), from which 
material was taken for the vaccination of James 
Phipps below in 1796 
History of Smallpox 
Vaccination 
* Henderson DA, Moss M, Smallpox and Vaccinia in Vaccines, 3rd edition, 1999 
1805 Growth of virus on the flank of a calf in Italy. 
1864 Publicity about vaccine production at a 
medical congress. 
After WWI Most of Europe smallpox free. 
After WWII Transmission interrupted in Europe and 
North America. 
1940’s Stable freeze-dried vaccine perfected by 
Collier. 
Smallpox Endemic Areas 1945 
Endemic smallpox 
History of Smallpox  
Eradication 
† Henderson DA, Moss B, Smallpox and Vaccinia in Vaccines, 3rd edition, 1999 
1950 Pan American Sanitary Organization 
decides to undertake eradication 
hemisphere-wide. 
1959 World Health Assembly adopts goal to 
eradicate smallpox. 
1966 World Health Assembly decides to 
intensify eradication and provide more 
funds. 
Principal Indicators of Eradicability 
• Humans essential for the life cycle. 
• Practical diagnostic tools. 
• Effective intervention capable of 
interrupting transmission. 
* Dowdle WR, Hopkins DR, The Eradication of Infectious Diseases, John Wiley 
& Sons, Chichester 1998. pp47-59 
Smallpox Endemic Areas 1967 
Endemic Importations Transmission Interrupted 
R & D Contributions 
Bifurcated Needle 
98%+ take 
Freeze-Dried 
Smallpox Vaccine 
Smallpox Eradication Strategy 
1. Mass vaccination campaigns in each 
country, using vaccine of ensured 
potency that would reach >80% of 
population. 
2. Development of a system to detect 
and contain cases and outbreaks. 
† Henderson DA, Moss B, Smallpox and Vaccinia in  Vaccines, 3rd edition, 1999 
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Herd Immunity Thresholds for Selected 
Vaccine-Preventable Diseases 
Immunization Levels 
Disease Ro Herd Immunity 
1999 
19-35 
Months 
1997-1998 
Pre-School 
Diphtheria 6-7 85%* 83%* 9% 
Measles 12-18 83-94% 92% 96% 
Mumps 4-7 75-86% 92% 97% 
Polio 5-7 80-86% 90% 97% 
Rubella 6-7 83-85% 92% 97% 
Smallpox 5-7 80-85% __ __ 
*4 doses 
† Modified from Epid Rev 1993;15: 265-302, Am J Prev Med 2001; 20 (4S): 
88-153, MMWR 2000; 49 (SS-9); 27-38 
Assumptions About Smallpox 
 Prior to Eradication Program 
• Highly contagious 
• Vaccine-induced immunity short-lived 
• High vaccination coverage needed to 
meet herd-immunity threshold 
What Was Learned about Smallpox  
Transmission  During the Eradication Program 
• Common transmission: Airborne by droplets  
– Close, face-to-face contact 
– Greater transmission with prolonged contact 
• Rare transmission: Airborne over long distance 
– More frequently seen in hospital associated 
outbreaks where cough was present 
• No carrier state 
• Rare transmission: fomites 
– Bedclothes, linens, blankets.  
• No evidence transmission by: food, water. 
What Was Learned about Smallpox 
Transmission  During the Eradication Program 
• Vaccine can provide protection for several 
years but full protection decreases over time 
• Vaccination soon after exposure can still 
provide some degree of protection  
• Transmission did not occur before onset of 
symptoms 
• Surveillance and targeted vaccination could 
significantly decrease transmission during 
outbreaks 
Factors Influencing Smallpox Spread 
• Temperature/Humidity – Lower 
temperature/humidity, higher viability 
• Intensity and duration of contact 
• Length of contagious period 
• Coughing/sneezing 
Exposure Factors for Smallpox 
West Pakistan, 1968-1970 
 
Exposure Factor  
Contacts  
(N) 
Cases  
(N) 
AR 
(%) 
Residence status  
Same house  
Same compound  
 
258 
206 
 
45 
45 
 
17.4 
22.3 
Pattern of exposure  
Constant  
Daily  
 
302 
160 
 
81 
10 
 
26.8 
6.3 
Duration of Exposure  
> 7 days  
<7 days  
 
449 
15 
 
91 
0 
 
20.3 
0 
Heiner et al Amer J Epidemiol 1971; 91:316-326 
Secondary Attack Rate for Smallpox 
Among Unvaccinated Household Contacts 
2° Attack Rate(%) # Studies 
36.9 - 47 5 
73.3 – 88.4 3 
Average 58.4% 
Average for vaccinated 3.8% 
(1.2-26.2) 
† Adapted from Fenner F et al. Smallpox and its Eradication, pp200 
Bull WHO 1975; 52: 209-222 
Source 
Contacts in 
addition to  
index case 
Contacts 
without history 
of vaccination 
Interval between onset of 
symptoms in index case and 
onset of symptoms in last 
compound case 
Nigeria (Abakaliki) 21 4 31 days 
Nigeria (Abakaliki) 
 32 14 47 days 
Nigeria (Abakaliki) 
 14 5 51 days 
United Rep. of 
Cameroon (N’Game) ? 4 Approx. 53 days 
Nigeria  
(Adepe-Ipiga) 30 27 Approx. 60 days 
Nigeria (Gerere) 24 15 Approx. 80 days 
Examples of Slow Smallpox 
Transmission Within a Single Compound 
Bull WHO 1975; 52: 209-222 
Examples of Slow Smallpox 
Transmission Within a Single Compound 
Source Susceptibles 
Exposed 
Smallpox case Cases per 100 
Susceptibles 
Exposed 
Nigeria 
(abakaliki) 
27 12 44.4 
United Rep. of 
Cameroon 
(N’Game) 
10 4 40.0 
Nigeria (Gerere) 45 12 26.2 
Airborne 
Spread of 
Smallpox 
in the 
Meschede 
Hospital 
Fenner. 1988.Fig. 4.9 
Recovery of Variola Virus from the 
Vicinity of Smallpox Patients 
Secondary Attack Rates by 
Pre-exposure Vaccination Status 
West Pakistan, Sheikhupura District 
Never vaccinated 26/27 96% 
Vaccinated within prior 10 
years 
5/115 4% 
Vaccinated >10 years 
previously 
8/65 12% 
†Adapted from Mack et al, Summarized in Fenner et al. Smallpox and its eradication, pg 688 
Duration of Protection 
Age Group 
Vaccination in 
Infancy Case-Fatality Rate 
0–4 
Yes 0% 
No 45% 
5-14 
Yes 0% 
No 10.5% 
15-29 
Yes 0.7% 
No 13.9% 
30-49 
Yes 3.7% 
No 54.2% 
>50  
Yes 5.5% 
No 50.0% 
†From Outbreak in Liverpool, England, 1902-1903  In Fenner F et al. Smallpox and its 
Eradication, pp53 
Case-Fatality Rate of Smallpox After 
Importations into Western Countries  
1950-1971 
†In Fenner F et al. Smallpox and its Eradication, pp53 
Successfully Vaccinated Case-Fatality Rate 
Never 52% 
Only after the exposure 29% 
0-10 years before exposure 1.4% 
11-20 years before exposure 7% 
> 20 years before exposure 11% 
Effects of Post Exposure Vaccination 
2° Attack Rate 
(Rao 1968)             Primary vaccination post exposure 29.5% 
Never vaccinated 47.6% 
(Mack 1972)     1° vaccination <10 days post exposure 75.0 
Never vaccinated 96.3 
(Helmer 1971)      Vaccinated or revaccinated <7 days 1.9 
Never Vaccinated 21.8 
† Adapted from Fenner F et al. Smallpox and its Eradication, pp 591 
Surveillance and Containment 
Strategy 
• Search for cases 
• Containment of spread 
by vaccinating primary 
contacts and their 
contacts 
• Most efficient strategy 
Case(s) 
Contacts to Case(s) 
Contacts to Contacts 
Progression of Smallpox 
Source:  Foege, Lane, and Millar, Am J. Epi, 1969  
Progression of Smallpox 
Source:  Foege, Lane, and Millar, Am J. Epi, 1969  
Last Village with Variola Major 
Kuralia, Bhola 
Last Cases of Smallpox** 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Rahima Banu – 16 October 1975 
Variola Major-Bangladesh 
Ali Maow Maalin – 26 October 1977 
Variola Minor-Somalia 
** Two laboratory acquired cases occurred in UK in 1978 

1980 
Why Worry About Smallpox? 
• Allegations that 
Soviet BW program 
produced smallpox 
virus for use in 
bombs and ICBMs  
• Concerns that 
smallpox virus could 
be obtained and 
used by others as 
terrorist weapon 
JAMA 1999; 281: 2127-2137 
The Faces of Smallpox 
